Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

John T. Wei(VA Center for Clinical Management Research), Rodney L. Dunn(University of Michigan–Ann Arbor), Mark S. Litwin(University of California, Los Angeles), Howard M. Sandler, Martin G. Sanda(National Cancer Institute)

Urology

December 1, 2000

10.1016/s0090-4295(00)00858-x

Cited by 1,503

Abstract

Related Papers

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne|PubMed|1992|34k

Statistical Abstract of the <scp>U</scp> nited <scp>S</scp> tates

|Encyclopedia of Statistical Sciences|2005|8.8k

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

David Cella, David S. Tulsky, Geoffrey V. Gray et al.|Journal of Clinical Oncology|1993|6k

The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups

Colleen A. McHorney, John E. Ware, Jing Lu et al.|Medical Care|1994|4.5k

The American Urological Association Symptom Index for Benign Prostatic Hyperplasia

Michael J. Barry, Floyd J. Fowler, Michael P. O’Leary et al.|The Journal of Urology|1992|3.4k